drugset / Trial / NCT06713590
A Study to Evaluate a Single-Dose Subcutaneous Axatilimab Compared With Intravenous Axatilimab in Healthy Participants
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will be conducted to evaluate a Single-Dose Subcutaneous (SC) Axatilimab Compared With Intravenous Axatilimab in Healthy Participants.
Timeline
- Start
- 2025-01-14
- Primary completion
- 2025-06-06
- Completion
- 2025-06-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Axatilimab | Monoclonal antibody | — | Intravenous |
Indications
No indication recorded.